Equities

New Ray Medicine International Holding Ltd

New Ray Medicine International Holding Ltd

Actions
  • Price (HKD)0.046
  • Today's Change-0.003 / -6.12%
  • Shares traded640.00k
  • 1 Year change+2.22%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments104154150
Total Receivables, Net2405464
Total Inventory3135125
Prepaid expenses2.864517
Other current assets, total--115127
Total current assets378404484
Property, plant & equipment, net293431
Goodwill, net------
Intangibles, net2.861219
Long term investments8090128
Note receivable - long term------
Other long term assets------
Total assets492540662
LIABILITIES
Accounts payable0.34----
Accrued expenses4.004.986.04
Notes payable/short-term debt0011
Current portion long-term debt/capital leases0.290.990.54
Other current liabilities, total0.921.881.53
Total current liabilities5.567.8519
Total long term debt00.290.92
Total debt0.291.2813
Deferred income tax5.806.059.06
Minority interest------
Other liabilities, total------
Total liabilities111429
SHAREHOLDERS EQUITY
Common stock848484
Additional paid-in capital608608608
Retained earnings (accumulated deficit)(3.68)2089
Treasury stock - common------
Unrealized gain (loss)(185)(166)(153)
Other equity, total(22)(20)4.98
Total equity480526633
Total liabilities & shareholders' equity492540662
Total common shares outstanding1,6721,6721,672
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.